Review
Published on 07 May 2026
Antimycobacterial peptides as natural therapeutics for tuberculosis: mechanisms and structural features
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1769369
- 349 views
Type at least 3 characters
120 articles
articles
Original Research
Accepted on 30 Apr 2026
Linezolid MIC Creep Among Clinically Significant S. aureus: A Retrospective Eight-Year Study
in Antibiotic Resistance
Frontiers in Antibiotics
- 125 views
Original Research
Accepted on 29 Apr 2026
Impact of a Structured Urine Culture Request Form on Antimicrobial Stewardship in Urinary Tract Infections at a Tertiary Care Hospital in India
in Enhanced Epidemiology and Preventive Strategies
Frontiers in Antibiotics
- 139 views
Review
Published on 23 Apr 2026
Microbial interactions of EDTA: recent advances and biological applications in the context of natural product modulation
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1767602
- 693 views
Original Research
Accepted on 21 Apr 2026
Empirical Antibiotic Prescribing in COVID-19 Patients: Patterns and Predictors in a Resource-Constrained Central Indian Setting
in Antibiotics in Clinical Settings
Frontiers in Antibiotics
- 193 views
Review
Published on 13 Apr 2026
Translational barriers to phage endolysin deployment for antimicrobial resistance control in Africa
in Antibiotic Resistance
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1815611
- 476 views
Original Research
Published on 08 Apr 2026
Simultaneous measurement of 16S-rRNA and pre-16S-rRNA as a strategy to monitor clinical tuberculosis
in Antibiotics in Clinical Settings
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1760862
- 424 views
Review
Published on 06 Apr 2026
Traditional medicine and natural product based therapeutics in gingivitis management and microbial interactions
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1764314
- 607 views
Original Research
Published on 06 Apr 2026
Awareness and practices regarding antimicrobial resistance among livestock farmers in Northern Uganda
in Antibiotic Resistance
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1745965
- 411 views
Review
Published on 25 Mar 2026
Antimicrobial peptides: emerging next-generation strategy for sustainable plant disease management
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1766594
- 777 views
Original Research
Published on 12 Mar 2026
Efficacy of a novel thermo-reversible wound gel against antibiotic tolerant biofilm
in Antibiotic Resistance
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1773630
- 692 views
Correction
Published on 02 Mar 2026
Correction: Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trials
in Antibiotics in Clinical Settings
Frontiers in Antibiotics
doi 10.3389/frabi.2025.1748877
- 549 views
Mini Review
Published on 26 Feb 2026
Beyond antibiotics: the expanding horizon of microbial natural products
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1768331
- 508 views
Editorial
Published on 24 Feb 2026
Editorial: Emerging trends in phage therapeutics to overcome antibiotic resistance
in Antibiotics in Clinical Settings
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1788766
- 547 views
Review
Published on 24 Feb 2026
Overcoming Candida biofilm resistance: targeting persister cells with probiotic-derived metabolites
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1767028
- 748 views
Correction
Published on 11 Feb 2026
Correction: Phage biobanks as enabling infrastructure for precision phage therapy in the era of antimicrobial resistance
in Antibiotics in Clinical Settings
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1804100
- 437 views
Review
Published on 10 Feb 2026
Natural product based approaches to overcome Candida glabrata and emerging AMR threats
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1767032
- 978 views
Perspective
Published on 30 Jan 2026
Phage biobanks as enabling infrastructure for precision phage therapy in the era of antimicrobial resistance
in Antibiotics in Clinical Settings
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1772871
- 1,898 views
- 1 citation
Original Research
Published on 28 Jan 2026
Activity of Biocidin® against microbial biofilms
in Antibiotic Development
Frontiers in Antibiotics
doi 10.3389/frabi.2025.1692653
- 2,509 views
Review
Published on 28 Jan 2026
Current status of antimicrobial resistance in Indian healthcare system: combating antimicrobial resistance with precision medicine
in Antibiotics in Clinical Settings
Frontiers in Antibiotics
doi 10.3389/frabi.2026.1632790
- 2,997 views
- 2 citations
Original Research
Published on 27 Jan 2026
Antimicrobial resistance and real-time PCR detection of blaKPC in Klebsiella pneumoniae isolated from wound infections in a tertiary care hospital
in Antibiotic Resistance
Frontiers in Antibiotics
doi 10.3389/frabi.2025.1700157
- 1,576 views
Original Research
Published on 23 Jan 2026
Assessment of antimicrobial use and stewardship practices among animal health practitioners, veterinary drug retailers and cattle keepers in Mvomero, Tanzania
in Antibiotic Resistance
Frontiers in Antibiotics
doi 10.3389/frabi.2025.1688828
- 1,140 views
Original Research
Published on 12 Jan 2026
Stakeholder perspectives on a hypothetical rapid test for antibiotic resistant bacteria: an exploratory study
in Antibiotic Resistance
Frontiers in Antibiotics
doi 10.3389/frabi.2025.1729093
- 973 views
Original Research
Published on 18 Dec 2025
Human–environmental overlap of resistant Enterobacterales: genomic evidence linking coastal waters and community carriage of antimicrobial resistance in a low- and middle-income setting
in Antibiotic Resistance
Frontiers in Antibiotics
doi 10.3389/frabi.2025.1715797
- 1,900 views